$ Value
$0
Shares
946,107
Price
$0
Filed
Apr 7
Insider
Name
Bagai Shaun
Title
Chief Executive Officer
CIK
0001862613
Roles
Transaction Details
Transaction Date
2026-04-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
946,107
Footnotes
On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.
Filing Info
Bagai Shaun's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-03-20 | RNXT | ▲ | — |
| 2026-03-20 | RNXT | ▲ | — |
| 2025-12-18 | RNXT | ▲ | $5K |
| 2025-12-17 | RNXT | ▲ | $4K |
| 2025-08-25 | RNXT | ▲ | $5K |
| 2025-08-22 | RNXT | ▲ | $5K ★ |
| 2025-07-01 | RNXT | A | $0 |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-03-20 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |